Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06481670 · ClinicalTrials.gov registry record · NA
Carbohydrate Fluids and Post Operative Nausea and Vomiting
A NA study, sponsored by Boston Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT06481670 is a NA study that has not yet begun recruiting, run by Boston Medical Center. The registered enrollment target is 32 participants.
The verdict
NCT06481670, a NA study, has not yet begun recruiting, sponsored by Boston Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study is a prospective randomized clinical controlled trial testing the effects of pre-operative \>50 g pre-operative carbohydrate fluids (apple juice) on a patient's post-operative nausea and vomiting (PONV) incidence and intensity. Optimizing fluid therapy in the peri-operative setting has been proven to improve patient outcomes and reduce complications and length of hospital stay. Based on practice guidelines under the American Society of Anesthesiologists, pre-operative hydration with complex carbohydrate drinks is safe and should be encouraged as it helps with improving metabolism to an anabolic state, decreases insulin resistance, reduces anxiety, and reduces PONV. While pre-operative carbohydrate (CHO) fluids have already been studied and adopted by other surgical specialities (Vascular, General Surgery, Orthopaedics, etc.), this has not yet been studied in oral and maxillofacial surgery, especially at Boston Medical Center (BMC). During surgery, each participant will undergo our current Enhanced Recovery After Surgery "ERAS" protocol, which includes general anesthesia using inhalational gas, judicious IV fluids, intra-operative steroid and ondansetron (anti-emetic), use of 0.5% bupivacaine local anesthesia per quadrant at surgery end time, use of a throat pack, and orogastric/nasogastric (OG/NG) tube suctioning prior to extubation to minimize ingestion of blood. Pain and anxiety medications prior to and during surgery include 2 mg midazolam, fentanyl per anesthesia, toradol, and dexmedetomidine. Having this protocol will help minimize confounding variables that could affect the primary outcome-- incidence and severity of PONV. The objectives for this research are: * To evaluate if pre-operative clear CHO help reduce incidence and intensity of PONV. * To assess if pre-operative clear carbohydrate fluids affect length of hospital stay * To determine if pre-operative CHO reduce patient's pre-/post-operative anxiety * To compare the amount/number of opio
Interventions
- OTHER Carbohydrate drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2026-09 |
| Est. Completion | 2027-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06481670
The ClinicalTrials.gov registry entry for NCT06481670 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carbohydrate drink is the first listed.
NCT06481670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06481670 about?
NCT06481670 is a clinical study titled "Carbohydrate Fluids and Post Operative Nausea and Vomiting". This study is a prospective randomized clinical controlled trial testing the effects of pre-operative \>50 g pre-operative carbohydrate fluids (apple juice) on a patient's post-operative nausea and vomiting (PONV) incidence and intensity. Optimizing fluid therapy in the peri-operative setting has be...
What is the current status of trial NCT06481670?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2026-09. Estimated completion is 2027-03.
What interventions are being tested in trial NCT06481670?
The interventions under investigation include: Carbohydrate drink (OTHER).
Who is sponsoring clinical trial NCT06481670?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.